Verastem, Inc. Gain (Loss) on Extinguishment of Debt
Verastem, Inc. (VSTM) reported Gain (Loss) on Extinguishment of Debt of -$1.83 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-06
- Verastem, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
- Verastem, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00.
- Verastem, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
- Verastem, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-03-31 was -$1.83M.
- Verastem, Inc. gain (loss) on extinguishment of debt for fiscal 2025 was -$1.83M.
- Verastem, Inc. gain (loss) on extinguishment of debt for fiscal 2020 was -$1.58M.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | -$1.83M 10-K · filed 2026-03-04 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | -$1.83M 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.83M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | -$1.83M 10-Q · filed 2026-05-07 | ||||
| 2025-01-13 | -$1.80M 10-Q · filed 2026-08-06 | ||||
| 2020-12-31 | -$1.58M 10-K · filed 2021-03-18 | -$1.58M 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |